The Neurobiology of Resilience: Complexity and Hope

James W. Murrough; Scott J. Russo

doi:10.1016/j.biopsych.2019.07.016

The Neurobiology of Resilience: Complexity and Hope

Research output: Contribution to journal › Comment/debate

11 Scopus citations

Original language	English
Pages (from-to)	406-409
Number of pages	4
Journal	Biological Psychiatry
Volume	86
Issue number	6
DOIs	https://doi.org/10.1016/j.biopsych.2019.07.016
State	Published - 15 Sep 2019

Access to Document

10.1016/j.biopsych.2019.07.016

Cite this

@article{1a4e6f3ae646457ba8660d08d15a6e9d,

title = "The Neurobiology of Resilience: Complexity and Hope",

author = "Murrough, {James W.} and Russo, {Scott J.}",

note = "Funding Information: This work was supported by National Institutes of Health Grant Nos. R01MH090264, R01MH104559, R01MH114882, and P50AT008661 (to SJR) and National Institutes of Health Grant Nos. R61MH111932, R21MH109771, and R01MH116953 (to JWM). We thank the editors for the opportunity to compile this special issue and the authors for their contributions. SJR has received grant support from Janssen Pharmaceuticals and Eli Lilly; and served as a consultant for Janssen, Danone, and Sunovion. JWM has provided consultation services to Otsuka, Clexio Biosciences, Boehreinger Ingelheim, Sage Therapeutics, FSV7, Novartis, Allergan, Fortress Biotech, Janssen Research and Development, Medavante-Prophase, and Global Medical Education; has received research support from Avanir Pharmaceuticals, Inc.; and is named on a patent pending for neuropeptide Y as a treatment for mood and anxiety disorders. The Icahn School of Medicine (employer of JWM) is named on a patent and has entered into a licensing agreement and will receive payments related to the use of ketamine or esketamine for the treatment of depression and is also named on a patent related to the use of ketamine for the treatment of PTSD. JWM is not named on these patents and will not receive any payments. Funding Information: This work was supported by National Institutes of Health Grant Nos. R01MH090264 , R01MH104559 , R01MH114882 , and P50AT008661 (to SJR) and National Institutes of Health Grant Nos. R61MH111932 , R21MH109771 , and R01MH116953 (to JWM). ",

year = "2019",

month = sep,

day = "15",

doi = "10.1016/j.biopsych.2019.07.016",

language = "English",

volume = "86",

pages = "406--409",

journal = "Biological Psychiatry",

issn = "0006-3223",

publisher = "Elsevier USA",

number = "6",

}

TY - JOUR

T1 - The Neurobiology of Resilience

T2 - Complexity and Hope

AU - Murrough, James W.

AU - Russo, Scott J.

N1 - Funding Information: This work was supported by National Institutes of Health Grant Nos. R01MH090264, R01MH104559, R01MH114882, and P50AT008661 (to SJR) and National Institutes of Health Grant Nos. R61MH111932, R21MH109771, and R01MH116953 (to JWM). We thank the editors for the opportunity to compile this special issue and the authors for their contributions. SJR has received grant support from Janssen Pharmaceuticals and Eli Lilly; and served as a consultant for Janssen, Danone, and Sunovion. JWM has provided consultation services to Otsuka, Clexio Biosciences, Boehreinger Ingelheim, Sage Therapeutics, FSV7, Novartis, Allergan, Fortress Biotech, Janssen Research and Development, Medavante-Prophase, and Global Medical Education; has received research support from Avanir Pharmaceuticals, Inc.; and is named on a patent pending for neuropeptide Y as a treatment for mood and anxiety disorders. The Icahn School of Medicine (employer of JWM) is named on a patent and has entered into a licensing agreement and will receive payments related to the use of ketamine or esketamine for the treatment of depression and is also named on a patent related to the use of ketamine for the treatment of PTSD. JWM is not named on these patents and will not receive any payments. Funding Information: This work was supported by National Institutes of Health Grant Nos. R01MH090264 , R01MH104559 , R01MH114882 , and P50AT008661 (to SJR) and National Institutes of Health Grant Nos. R61MH111932 , R21MH109771 , and R01MH116953 (to JWM).

PY - 2019/9/15

Y1 - 2019/9/15

UR - http://www.scopus.com/inward/record.url?scp=85070899070&partnerID=8YFLogxK

U2 - 10.1016/j.biopsych.2019.07.016

DO - 10.1016/j.biopsych.2019.07.016

M3 - Comment/debate

C2 - 31466560

AN - SCOPUS:85070899070

SN - 0006-3223

VL - 86

SP - 406

EP - 409

JO - Biological Psychiatry

JF - Biological Psychiatry

IS - 6

ER -